Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent’s Neuroprotective Effects following Surgery
Postoperative delirium (POD) represents a perioperative neurocognitive disorder that has dreaded ramifications on a patient’s recovery from surgery. Dexmedetomidine displays multiple mechanisms of neuroprotection to assist in preventing POD as a part of a comprehensive anesthetic care plan. This rev...
Main Authors: | Vincent Bargnes, Brian Oliver, Emily Wang, Seth Greenspan, Zhaosheng Jin, Isaac Yeung, Sergio Bergese |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/10/1453 |
Similar Items
-
Anesthesia, the developing brain, and dexmedetomidine for neuroprotection
by: Alexandra Tsivitis, et al.
Published: (2023-06-01) -
Effect of dexmedetomidine on postoperative delirium in patients undergoing awake craniotomies: study protocol of a randomized controlled trial
by: Muhan Li, et al.
Published: (2023-09-01) -
Postoperative delirium after coronary artery bypass graft surgery: Dexmedetomidine infusion alone or with the addition of oral melatonin
by: Ramy Mahrose, et al.
Published: (2021-01-01) -
Dexmedetomidine reduces the incidence of postoperative delirium after cardiac surgery: a meta-analysis of randomized controlled trials
by: Peng Li, et al.
Published: (2021-05-01) -
Feasibility of low-dose dexmedetomidine for prevention of postoperative delirium after intracranial operations: a pilot randomized controlled trial
by: Xuan He, et al.
Published: (2021-12-01)